Director, President & CEO · Evommune, Inc. · Common Stock
Side
A
Value
$7,827
Shares
1,115
Price
$7.02
Executed
Sep 30, 2026
Disclosed
Oct 15, 2026
Disclosure timeline15 days from execution to publication · legal deadline 2 business days
Sep 30 executedOct 15, 2026 disclosed
EVMN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
$8K reported value · 0.2% of prior position
Filing timing+10 / 15
Disclosed 11 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Pena Luis C. filed this Form 4 reporting a grant or award of EVMN on Sep 30, 2026. It became public on Oct 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President & CEO
Pena Luis C.cik:0001620548
Issuer
Evommune, Inc.cik:0002044725
Revision history · 0
No field has changed since this record was first ingested.
